Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

405
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
405
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Heterogeneity of severe asthma in Europe: a SHARP-er view.

The Lancet. Respiratory medicine·2026
Same author

[Documentation of biological treatment in asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Enhanced BDNF in Asthma: Does It Overrule Depression?

The journal of allergy and clinical immunology. In practice·2026
Same author

[Clinical and economic role of FeNO measurements in adults with asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Clinical phenotyping improves choices of biologics in asthma.

Lancet (London, England)·2026

相关实验视频

Updated: Jul 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

喘治疗的概念通过时代.

Marek Lommatzsch1

  • 1Department of Pneumology, Rostock University Medical Centre, University of Rostock, Rostock, Germany.

Allergologie select
|January 22, 2024
PubMed
概括

新的喘治疗方法,包括吸入类固醇和生物药物,将重点从症状控制转移到预防和缓解. 实现喘缓解需要基于精确的患者表型和生物标志物分析的个性化治疗计划.

科学领域:

  • 肺部病理学 肺部病理学
  • 过敏学 过敏学
  • 药理学 药理学 是一个学科.

背景情况:

  • 喘治疗已经从症状管理演变为预防方法.
  • 改变疾病的抗喘药物 (DMAADs),生物药物和免疫疗法是关键的进展.
  • 喘缓解的概念现在是治疗的主要目标.

研究的目的:

  • 定义喘缓解及其类型.
  • 为实现喘缓解引入治疗到目标的策略.
  • 突出精确的患者表型对于有效的喘管理的重要性.

主要方法:

  • 喘缓解的分类是自发的,治疗后的和治疗中的.
  • 应用治疗到点的方法,类似于其他慢性炎症疾病.
  • 重点是全面的患者表型:病史,肺功能,过敏测试和2型生物标志物.

主要成果:

  • 喘缓解的特点是持续的症状缺失,没有恶化,没有系统性类固醇的肺功能稳定.
  • 通过量身定制的,有针对性的疗法,可以成功实现喘缓解.
  • 个性化治疗需要详细的诊断评估.

结论:

关键词:
这就是DMAADs.喘 喘 是一种缓解缓解是一种缓解.预防症状 预防症状

更多相关视频

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.5K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K

相关实验视频

Last Updated: Jul 5, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

3.5K
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.6K
  • 现代喘管理旨在通过使用DMAADs,生物药物和免疫疗法缓解喘.
  • 治疗到目标策略指导个性化治疗以实现缓解.
  • 精确的表型和生物标记分析对于优化喘缓解策略至关重要.